SpaceX Has Tumbled 27% From Its Recent Peak. Time to Buy the Dip?

SpaceX shares are down ~27% from an IPO high around $225.64, but the company still carries a ~$2.16T market cap and trades at ~115x last year’s $18.7B revenue. The article highlights upside from AI processing contracts, Starlink expansion, and rocket services growth, but warns that net losses (~$4.9B last year) are likely to widen as major AI-related infrastructure spending ramps. Net-net, it frames the valuation as highly growth-dependent and suggests waiting for a better entry point.

Analysis

The key mechanism here is duration, not the headline pullback. A business mix tilted toward capex-heavy, low-visibility growth means the equity should trade on confidence in future operating leverage, and that confidence usually breaks before the revenue line does. In that setup, the first leg down is often just the market re-pricing the probability of further dilution, higher burn, or a slower path to free cash flow; the second leg comes if management has to fund growth before the new revenue streams are truly visible.

Second-order, the cleanest beneficiaries are upstream suppliers to AI infrastructure, with NVDA the most obvious public proxy if the compute buildout is real. But the bigger market effect may be negative for the broader "growth at any price" basket: a public de-rating in a marquee, scarce asset tends to compress multiples across unprofitable AI and space-adjacent names because it raises the discount rate on every story stock. That matters more for sentiment than for direct revenue linkages.

The contrarian miss is that a high sales multiple can look less absurd very quickly if the business proves recurring revenue quality and narrows losses, especially in Starlink-like segments with better visibility. The thesis is falsified by evidence of operating leverage: a smaller loss than expected, lower capex intensity, or a credible path to self-funding growth over the next 1-3 quarters. Without that, any bounce is likely a tradable squeeze rather than a durable rerating.

Key Decisions for Investors

• Avoid initiating long exposure in SPCX here; wait for either another 15-20% reset or a filing/update that shows losses are stabilizing. Time horizon: 1-3 months. Falsifier: next disclosure shows improving margin trajectory.
• If borrow/liquidity exists, consider a tactical short SPCX against long NVDA as a relative-value expression of AI capex benefiting suppliers more reliably than the end-asset. Time horizon: 1-3 months. Risk/reward: defined if sized as a spread, with NVDA as the cleaner cash-flow beneficiary.
• For those who want downside convexity, use put spreads on SPCX rather than outright shorts: buy 1-3 month puts 10-15% below spot and finance with lower-strike sales. This targets a continued multiple compression leg while limiting premium burn.
• Watch for any secondary offering, financing rumor, or revised loss outlook; that is the real catalyst path, not daily price action. If the stock reclaims the post-IPO highs before the next financial update, cover bearish positions because the market is signaling scarcity premium is overpowering fundamentals.